Extracts containing CLPs of Bacillus amyloliquefaciens JN68 isolated from chicken intestines exert antimicrobial effects, particularly on methicillin-resistant Staphylococcus aureus and Listeria monocytogenes

Niazi A, Manzoor S, Bejai S, Meijer J and Bongcam-Rudloff E: Complete genome sequence of a plant associated bacterium Bacillus amyloliquefaciens subsp. plantarum UCMB5033. Stand Genomic Sci. 9:718–725. 2014. View Article : Google Scholar : PubMed/NCBI

Cai J, Liu F, Liao X and Zhang R: Complete genome sequence of Bacillus amyloliquefaciens LFB112 isolated from Chinese herbs, a strain of a broad inhibitory spectrum against domestic animal pathogens. J Biotechnol. 175:63–64. 2014. View Article : Google Scholar : PubMed/NCBI

Ait Kaki A, Chaouche N Kacem, Dehimat L, Milet A, Youcef-Ali M, Ongena M and Thonart P: Biocontrol and plant growth promotion characterization of Bacillus species isolated from calendula officinalis rhizosphere. Indian J Microbiol. 53:447–452. 2013. View Article : Google Scholar : PubMed/NCBI

Geetha I, Aruna R and Manonmani AM: Mosquitocidal Bacillus amyloliquefaciens: Dynamics of growth & production of novel pupicidal biosurfactant. Indian J Med Res. 140:427–434. 2014.PubMed/NCBI

Han JH, Shim H, Shin JH and Kim KS: Antagonistic activities of Bacillus spp. strains isolated from tidal flat sediment towards anthracnose pathogens Colletotrichum acutatum and C. gloeosporioides in South Korea. Plant Pathol J. 31:165–175. 2015. View Article : Google Scholar : PubMed/NCBI

Xu HM, Rong YJ, Zhao MX, Song B and Chi ZM: Antibacterial activity of the lipopetides produced by Bacillus amyloliquefaciens M1 against multidrug-resistant Vibrio spp. isolated from diseased marine animals. Appl Microbiol Biotechnol. 98:127–136. 2014. View Article : Google Scholar : PubMed/NCBI

Ruckert C, Blom J, Chen X, Reva O and Borriss R: Genome sequence of B. amyloliquefaciens type strain DSM7(T) reveals differences to plant-associated B. amyloliquefaciens FZB42. J Biotechnol. 155:78–85. 2011. View Article : Google Scholar : PubMed/NCBI

Xu Z, Shao J, Li B, Yan X, Shen Q and Zhang R: Contribution of bacillomycin D in Bacillus amyloliquefaciens SQR9 to antifungal activity and biofilm formation. Appl Environ Microbiol. 79:808–815. 2013. View Article : Google Scholar : PubMed/NCBI

Yuan J, Raza W, Huang Q and Shen Q: The ultrasound-assisted extraction and identification of antifungal substances from B. amyloliquefaciens strain NJN-6 suppressing Fusarium oxysporum. J Basic Microbiol. 52:721–730. 2012. View Article : Google Scholar : PubMed/NCBI

Zhao P, Quan C, Jin L, Wang L, Wang J and Fan S: Effects of critical medium components on the production of antifungal lipopeptides from Bacillus amyloliquefaciens Q-426 exhibiting excellent biosurfactant properties. World J Microbiol Biotechnol. 29:401–409. 2013. View Article : Google Scholar : PubMed/NCBI

Chi Z, Rong YJ, Li Y, Tang MJ and Chi ZM: Biosurfactins production by Bacillus amyloliquefaciens R3 and their antibacterial activity against multi-drug resistant pathogenic E. coli. Bioprocess Biosyst Eng. 38:853–861. 2015. View Article : Google Scholar : PubMed/NCBI

Kadaikunnan S, Rejiniemon T, Khaled JM, Alharbi NS and Mothana R: In-vitro antibacterial, antifungal, antioxidant and functional properties of Bacillus amyloliquefaciens. Ann Clin Microbiol Antimicrob. 14:92015. View Article : Google Scholar : PubMed/NCBI

Cao H, He S, Wei R, Diong M and Lu L: Bacillus amyloliquefaciens G1: A potential antagonistic bacterium against eel-pathogenic aeromonas hydrophila. Evid Based Complement Alternat Med. 2011:8241042011. View Article : Google Scholar : PubMed/NCBI

Ma Z, Hu J, Wang X and Wang S: NMR spectroscopic and MS/MS spectrometric characterization of a new lipopeptide antibiotic bacillopeptin B1 produced by a marine sediment-derived Bacillus amyloliquefaciens SH-B74. J Antibiot (Tokyo). 67:175–178. 2014. View Article : Google Scholar : PubMed/NCBI

Mora I, Cabrefiga J and Montesinos E: Cyclic lipopeptide biosynthetic genes and products, and inhibitory activity of plant-associated Bacillus against phytopathogenic bacteria. PLoS One. 10:e01277382015. View Article : Google Scholar : PubMed/NCBI

Nihorimbere V, Cawoy H, Seyer A, Brunelle A, Thonart P and Ongena M: Impact of rhizosphere factors on cyclic lipopeptide signature from the plant beneficial strain Bacillus amyloliquefaciens S499. FEMS Microbiol Ecol. 79:176–191. 2012. View Article : Google Scholar : PubMed/NCBI

Arrebola E, Jacobs R and Korsten L: Iturin A is the principal inhibitor in the biocontrol activity of Bacillus amyloliquefaciens PPCB004 against postharvest fungal pathogens. J Appl Microbiol. 108:386–395. 2010. View Article : Google Scholar : PubMed/NCBI

Arguelles-Arias A, Ongena M, Halimi B, Lara Y, Brans A, Joris B and Fickers P: Bacillus amyloliquefaciens GA1 as a source of potent antibiotics and other secondary metabolites for biocontrol of plant pathogens. Microb Cell Fact. 8:632009. View Article : Google Scholar : PubMed/NCBI

Vágvölgyi C, Sajben-Nagy E, Bóka B, Vörös M, Berki A, Palágyi A, Krisch J, Skrbić B, Durišić-Mladenović N and Manczinger L: Isolation and characterization of antagonistic Bacillus strains capable to degrade ethylenethiourea. Curr Microbiol. 66:243–250. 2013. View Article : Google Scholar : PubMed/NCBI

Kim PI, Bai H, Bai D, Chae H, Chung S, Kim Y, Park R and Chi YT: Purification and characterization of a lipopeptide produced by Bacillus thuringiensis CMB26. J Appl Microbiol. 97:942–949. 2004. View Article : Google Scholar : PubMed/NCBI

Maget-Dana R and Peypoux F: Iturins, a special class of pore-forming lipopeptides: Biological and physicochemical properties. Toxicology. 87:151–174. 1994. View Article : Google Scholar : PubMed/NCBI

Stein T: Bacillus subtilis antibiotics: Structures, syntheses and specific functions. Mol Microbiol. 56:845–857. 2005. View Article : Google Scholar : PubMed/NCBI

Yoshida S, Hiradate S, Tsukamoto T, Hatakeda K and Shirata A: Antimicrobial activity of culture filtrate of Bacillus amyloliquefaciens RC-2 isolated from mulberry leaves. Phytopathology. 91:181–187. 2001. View Article : Google Scholar : PubMed/NCBI

Benitez L, Correa A, Daroit D and Brandelli A: Antimicrobial activity of Bacillus amyloliquefaciens LBM 5006 is enhanced in the presence of Escherichia coli. Curr Microbiol. 62:1017–1022. 2011. View Article : Google Scholar : PubMed/NCBI

Arias A Arguelles, Ongena M, Devreese B, Terrak M, Joris B and Fickers P: Characterization of amylolysin, a novel lantibiotic from Bacillus amyloliquefaciens GA1. PLoS One. 8:e830372013. View Article : Google Scholar : PubMed/NCBI

Salazar JK, Wu Z, McMullen PD, Luo Q, Freitag NE, Tortorello ML, Hu S and Zhang W: PrfA-like transcription factor gene lmo0753 contributes to L-rhamnose utilization in Listeriamonocytogenes strains associated with human food-borne infections. Appl Environ Microbiol. 79:5584–5592. 2013. View Article : Google Scholar : PubMed/NCBI

Shalaby MA, Mohamed MS, Mansour MA and Abd El-Haffiz AS: Comparison of polymerase chain reaction and conventional methods for diagnosis of Listeria monocytogenes isolated from different clinical specimens and food stuffs. Clin Lab. 57:919–924. 2011.PubMed/NCBI

Neetoo H, Ye M and Chen H: Potential antimicrobials to control Listeria monocytogenes in vacuum-packaged cold-smoked salmon pâté and fillets. Int J Food Microbiol. 123:220–227. 2008. View Article : Google Scholar : PubMed/NCBI

Pérez-Rodriguez F, van Asselt ED, Garcia-Gimeno RM, Zurera G and Zwietering MH: Extracting additional risk managers information from a risk assessment of Listeria monocytogenes in deli meats. J Food Prot. 70:1137–1152. 2007. View Article : Google Scholar : PubMed/NCBI

Althaus D, Lehner A, Brisse S, Maury M, Tasara T and Stephan R: Characterization of Listeria monocytogenes strains isolated during 2011–2013 from human infections in Switzerland. Foodborne Pathog Dis. 11:753–758. 2014. View Article : Google Scholar : PubMed/NCBI

Pontello M, Guaita A, Sala G, Cipolla M, Gattuso A, Sonnessa M and Gianfranceschi MV: Listeria monocytogenes serotypes in human infections (Italy, 2000–2010). Ann Ist Super Sanita. 48:146–150. 2012. View Article : Google Scholar : PubMed/NCBI

Lisboa MP, Bonatto D, Bizani D, Henriques JA and Brandelli A: Characterization of a bacteriocin-like substance produced by Bacillus amyloliquefaciens isolated from the Brazilian Atlantic forest. Int Microbiol. 9:111–118. 2006.PubMed/NCBI

Sağdiç O, Ozkan G, Ozcan M and Ozçelik S: A study on inhibitory effects of Siğla tree (Liquidambar orientalis Mill. var. orientalis) storax against several bacteria. Phytother Res. 19:549–551. 2005. View Article : Google Scholar : PubMed/NCBI

Agarwal A and Aggarwal AN: Bone and joint infections in children: Acute hematogenous osteomyelitis. Indian J Pediatr. 2015.

Christiansen JG, Jensen HE, Johansen LK, Kochl J, Koch J, Aalbaek B, Nielsen OL and Leifsson PS: Porcine models of non-bacterial thrombotic endocarditis (NBTE) and infective endocarditis (IE) caused by Staphylococcus aureus: A preliminary study. J Heart Valve Dis. 22:368–376. 2013.PubMed/NCBI

Vos FJ, Kullberg BJ, Sturm PD, Krabbe PF, van Dijk AP, Wanten GJ, Oyen WJ and Bleeker-Rovers CP: Metastatic infectious disease and clinical outcome in Staphylococcus aureus and Streptococcus species bacteremia. Medicine (Baltimore). 91:86–94. 2012. View Article : Google Scholar : PubMed/NCBI

Hasanvand A, Ghafourian S, Taherikalani M, Jalilian FA, Sadeghifard N and Pakzad I: Antiseptic resistance in methicillin sensitive and methicillin resistant Staphylococcus aureus isolates from some major hospitals, Iran. Recent Pat Antiinfect Drug Discov. 10:105–112. 2015. View Article : Google Scholar : PubMed/NCBI

Kaur DC and Chate SS: Study of antibiotic resistance pattern in methicillin resistant Staphylococcus aureus with special reference to newer antibiotic. J Glob Infect Dis. 7:78–84. 2015. View Article : Google Scholar : PubMed/NCBI

McMaster J, Booth MG, Smith A and Hamilton K: Meticillin-resistant Staphylococcus aureus in the intensive care unit: Its effect on outcome and risk factors for acquisition. J Hosp Infect. 90:327–332. 2015. View Article : Google Scholar : PubMed/NCBI

Dancer SJ: Controlling hospital-acquired infection: Focus on the role of the environment and new technologies for decontamination. Clin Microbiol Rev. 27:665–690. 2014. View Article : Google Scholar : PubMed/NCBI

Lima ET, Filho RL Andreatti, Okamoto AS, Noujaim JC, Barros MR and Crocci AJ: Evaluation in vitro of the antagonistic substances produced by Lactobacillus spp. isolated from chickens. Can J Vet Res. 71:103–107. 2007.PubMed/NCBI

Chen H, Wang L, Su CX, Gong GH, Wang P and Yu ZL: Isolation and characterization of lipopeptide antibiotics produced by Bacillus subtilis. Lett Appl Microbiol. 47:180–186. 2008. View Article : Google Scholar : PubMed/NCBI

Østensvik Ø, From C, Heidenreich B, O'Sullivan K and Granum PE: Cytotoxic Bacillus spp. belonging to the B. cereus and B. subtilis groups in Norwegian surface waters. J Appl Microbiol. 96:987–993. 2004. View Article : Google Scholar : PubMed/NCBI

Zaghloul TI, Al-Bahra M and Al-Azmeh H: Isolation, identification, and keratinolytic activity of several feather-degrading bacterial isolates. Appl Biochem Biotechnol 70–72. 207–213. 1998. View Article : Google Scholar

Marroki A, Zúñiga M, Kihal M and Pérez-Martinez G: Characterization of lactobacillus from algerian goat's milk based on phenotypic, 16S rDNA sequencing and their technological properties. Braz J Microbiol. 42:158–171. 2011. View Article : Google Scholar : PubMed/NCBI

Tajbakhsh M, Nayer BN, Motavaze K, Kharaziha P, Chiani M, Zali MR and Klena JD: Phylogenetic relationship of Salmonella enterica strains in Tehran, Iran, using 16S rRNA and gyrB gene sequences. J Infect Dev Ctries. 5:465–472. 2011.PubMed/NCBI

Wang LT, Lee FL, Tai CJ and Kasai H: Comparison of gyrB gene sequences, 16S rRNA gene sequences and DNA-DNA hybridization in the Bacillus subtilis group. Int J Syst Evol Microbiol. 57:1846–1850. 2007. View Article : Google Scholar : PubMed/NCBI

Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W and Lipman DJ: Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25:3389–3402. 1997. View Article : Google Scholar : PubMed/NCBI

Tsuge K, Akiyama T and Shoda M: Cloning, sequencing, and characterization of the iturin A operon. J Bacteriol. 183:6265–6273. 2001. View Article : Google Scholar : PubMed/NCBI

Razafindralambo H, Paquot M, Hbid C, Jacques P, Destain J and Thonart P: Purification of antifungal lipopeptides by reversed-phase high-performance liquid chromatography. J Chromatogr. 639:81–85. 1993. View Article : Google Scholar : PubMed/NCBI

Perea Vélez M, Hermans K, Verhoeven TL, Lebeer SE, Vanderleyden J and De Keersmaecker SC: Identification and characterization of starter lactic acid bacteria and probiotics from Columbian dairyproducts. J Appl Microbiol. 103:666–674. 2007. View Article : Google Scholar : PubMed/NCBI

Zeriouh H, de Vicente A, Pérez-Garcia A and Romero D: Surfactin triggers biofilm formation of Bacillus subtilis in melon phylloplane and contributes to the biocontrol activity. Environ Microbiol. 16:2196–2211. 2014. View Article : Google Scholar : PubMed/NCBI

Zhao X, Han Y, Tan XQ, Wang J and Zhou ZJ: Optimization of antifungal lipopeptide production from Bacillus sp. BH072 by response surface methodology. J Microbiol. 52:324–332. 2014. View Article : Google Scholar : PubMed/NCBI

Wang J, Liu J, Wang X, Yao J and Yu Z: Application of electrospray ionization mass spectrometry in rapid typing of fengycin homologues produced by Bacillus subtilis. Lett Appl Microbiol. 39:98–102. 2004. View Article : Google Scholar : PubMed/NCBI

Tagg JR and McGiven AR: Assay system for bacteriocins. Appl Microbiol. 21:9431971.PubMed/NCBI

Pecci Y, Rivardo F, Martinotti MG and Allegrone G: LC/ESI-MS/MS characterisation of lipopeptide biosurfactants produced by the Bacillus licheniformis V9T14 strain. J Mass Spectrom. 45:772–778. 2010. View Article : Google Scholar : PubMed/NCBI

Vanittanakom N, Loeffler W, Koch U and Jung G: Fengycin-a novel antifungal lipopeptide antibiotic produced by Bacillus subtilis F-29-3. J Antibiot (Tokyo). 39:888–901. 1986. View Article : Google Scholar : PubMed/NCBI

Zhao P, Quan C, Wang Y, Wang J and Fan S: Bacillus amyloliquefaciens Q-426 as a potential biocontrol agent against Fusarium oxysporum f. sp. spinaciae. J Basic Microbiol. 54:448–456. 2014. View Article : Google Scholar : PubMed/NCBI

Yuan B, Wang Z, Qin S, Zhao GH, Feng YJ, Wei LH and Jiang JH: Study of the anti-sapstain fungus activity of Bacillus amyloliquefaciens CGMCC 5569 associated with Ginkgo biloba and identification of its active components. Bioresour Technol. 114:536–541. 2012. View Article : Google Scholar : PubMed/NCBI

Kröber M, Wibberg D, Grosch R, Eikmeyer F, Verwaaijen B, Chowdhury SP, Hartmann A, Pühler A and Schlüter A: Effect of the strain Bacillus amyloliquefaciens FZB42 on the microbial community in the rhizosphere of lettuce under field conditions analyzed by whole metagenome sequencing. Front Microbiol. 5:2522014.PubMed/NCBI

Huang J, Wei Z, Tan S, Mei X, Shen Q and Xu Y: Suppression of bacterial wilt of tomato by bioorganic fertilizer made from the antibacterial compound producing strain Bacillus amyloliquefaciens HR62. J Agric Food Chem. 62:10708–10716. 2014. View Article : Google Scholar : PubMed/NCBI

Yuan J, Zhang F, Wu Y, Zhang J, Raza W, Shen Q and Huang Q: Recovery of several cell pellet-associated antibiotics produced by Bacillus amyloliquefaciens NJN-6. Lett Appl Microbiol. 59:169–176. 2014. View Article : Google Scholar : PubMed/NCBI

He P, Hao K, Blom J, Rückert C, Vater J, Mao Z, Wu Y, Hou M, He P, He Y and Borriss R: Genome sequence of the plant growth promoting strain Bacillus amyloliquefaciens subsp. plantarum B9601-Y2 and expression of mersacidin and other secondary metabolites. J Biotechnol. 164:281–291. 2012. View Article : Google Scholar : PubMed/NCBI

Compaoré CS, Nielsen DS, Sawadogo-Lingani H, Berner TS, Nielsen KF, Adimpong DB, Diawara B, Ouédraogo GA, Jakobsen M and Thorsen L: Bacillus amyloliquefaciens ssp. plantarum strains as potential protective starter cultures for the production of Bikalga, an alkaline fermented food. J Appl Microbiol. 115:133–146. 2013. View Article : Google Scholar : PubMed/NCBI

Hajji S, Ghorbel-Bellaaj O, Younes I, Jellouli K and Nasri M: Chitin extraction from crab shells by Bacillus bacteria. Biological activities of fermented crab supernatants. Int J Biol Macromol. 79:167–173. 2015. View Article : Google Scholar : PubMed/NCBI

Alvarez F, Castro M, Principe A, Borioli G, Fischer S, Mori G and Jofré E: The plant-associated Bacillus amyloliquefaciens strains MEP2 18 and ARP2 3 capable of producing the cyclic lipopeptides iturin or surfactin and fengycin are effective in biocontrol of sclerotinia stem rot disease. J Appl Microbiol. 112:159–174. 2012. View Article : Google Scholar : PubMed/NCBI

Hsieh FC, Lin TC, Meng M and Kao SS: Comparing methods for identifying Bacillus strains capable of producing the antifungal lipopeptide iturin A. Curr Microbiol. 56:1–5. 2008. View Article : Google Scholar : PubMed/NCBI

Wang SL, Shih IL, Liang TW and Wang CH: Purification and characterization of two antifungal chitinases extracellularly produced by Bacillus amyloliquefaciens V656 in a shrimp and crab shell powder medium. J Agric Food Chem. 50:2241–2248. 2002. View Article : Google Scholar : PubMed/NCBI

Ongena M and Jacques P: Bacillus lipopeptides: Versatile weapons for plant disease biocontrol. Trends Microbiol. 16:115–125. 2008. View Article : Google Scholar : PubMed/NCBI